A 12-Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia
A 12-Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia
To evaluate the safety of pregabalin in patients with fibromyalgia.
Inclusion Criteria:
Exclusion Criteria: